Coll-Martinez C; Quintana E; Buxó M; Salavedra-Pont J; Gasull-Vicens L; Quiroga-Varela A; Costa-Frossard L, Villar LM, Fernández-Díaz E, Gracia J, Aladro Y, Méndez-Burgos A, Cerezo M, Ramió-Torrentà L, Gich J. "Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.." Multiple Sclerosis And Related Disorders (2022): -. Meca-Lallana JE; Fernández-Prada M; García Vázquez E; Moreno Guillén S; Otero Romero S; Rus Hidalgo M; Villar Guimerans LM; Eichau Madueño S; Fernández Fernández Ó; Izquierdo Ayuso G; Álvarez Cermeño JC; Arnal García C; Arroy "Consensus statement on the use of alemtuzumab in daily clinical practice in Spain." Neurología S0213-48533 (2022): 30146-. Mayneris-Perxachs J; Arnoriaga-Rodríguez M; Garre-Olmo J; Puig J; Ramos R; Trelis M; Burokas A; Coll C; Zapata-Tona C; Pedraza S; Pérez-Brocal V; Ramió L; Ricart W; Moya A; Jové M; Sol J; Portero-Otin M; Pamplona R; Maldonado "Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function." ISME Journal 16 (2022): 2181-2197. Martín-Aguilar L, Presas-Rodriguez S, Rovira À, Capellades J, Massuet-Vilamajó A, Ramió-Torrentà L, Tintoré M, Brieva-Ruiz L, Moral E, Cano-Orgaz A, Blanco Y, Batlle-Nadal J, Carmona O, Gea M, Hervás-García JV, Ramo-Tello C "Gadolinium-enhanced brain lesions in multiple sclerosis relapse.." Neurology (2022): -. Marina Gonzalez-Del-Rio; Carme Bertran-Noguer; Lluís Ramió-Torrentà; Edurne Zabaleta-Del-Olmo "Multiple sclerosis disease-related knowledge measurement instruments show mixed performance: a systematic review." Journal of Clinical Epidemiology 149 (2022): 60-82. Bravo GÁ, Cedeño RR, Casadevall MP, Ramió-Torrentà L "Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives.." Cells (2022): -. Zapata C; Burokas A; Blasco G; Coll C; Escrichs A; Biarnés C; Moreno-Navarrete JM; Puig J; Garre-Olmo J; Ramos R; Pedraza S; Brugada R; Vilanova JC; Serena J; Gich J; Ramió-Torrentà L; Pérez-Brocal V; Moya A; Pamplona R; Sol "Microbiota alterations in proline metabolism impact depression." Cell Metabolism 34 (2022): 681-701. Escrichs A, Biarnes C, Garre-Olmo J, Fernández-Real JM, Ramos R, Pamplona R, Brugada R, Serena J, Ramió-Torrentà L, Coll-De-Tuero G, Gallart L, Barretina J, Vilanova JC, Mayneris-Perxachs J, Essig M, Figley CR, Pedraza S, Pui "Correction to: Whole-brain dynamics in aging: disruptions in functional connectivity and the role of the rich club.." Cerebral Cortex 32 (2022): 2061-2062. Mayneris-Perxachs J; Castells-Nobau A; Arnoriaga-Rodríguez M; Garre-Olmo J; Puig J; Ramos R; Martínez-Hernández F; Burokas A; Coll C; Moreno-Navarrete JM; Zapata-Tona C; Pedraza S; Pérez-Brocal V; Ramió-Torrentà L; Ricart W; "Caudovirales bacteriophages are associated with improved executive function and memory in flies, mice, and humans." Cell Host & Microbe 30 (2022): 340--356. Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group "Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.." Neurology: Neuroimmunology and Neuroinflammation (2022): -. Contreras-Rodriguez O; Arnoriaga-Rodríguez M; Miranda-Olivos R; Blasco G; Biarnés C; Puig J; Rivera-Pinto J; Calle ML; Pérez-Brocal V; Moya A; Coll C; Ramió-Torrentà L; Soriano-Mas C; Fernandez-Real JM "Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance." International Journal of Obesity 46 (2022): 30-38. Aliaga-Gaspar P; Hurtado-Guerrero I; Ciano-Petersen NL; Urbaneja P; Brichette-Mieg I; Reyes V; Rodriguez-Bada JL; Alvarez-Lafuente R; Arroyo R; Quintana E; Ramió-Torrentà L; Alonso A; Leyva L; Fernández O; Oliver-Martos B; "Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment." Frontiers In Immunology 12 (2021): 778204-. Ramo-Tello C, Blanco Y, Brieva L, Casanova B, Martínez-Cáceres E, Ontaneda D, Ramió-Torrentá L, Rovira À "Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses.." Journal Of Personalized Medicine (2021): -. Trojano M; Ramió-Torrentà L; Grimaldi LM; Lubetzki C; Schippling S; Evans KC; Ren Z; Muralidharan KK; Licata S; Gafson AR; "A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis." Multiple Sclerosis Journal 27 (2021): 2240-2253. Coll-Martinez C; Quintana E; Salavedra-Pont J; Buxó M; González-Del-Rio M; Gómez I; Muñoz-San Martín M; Villar LM; Álvarez-Bravo G; Robles-Cedeño R; Ramió-Torrentà L; Gich J; "Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis." Brain And Behavior 11 (2021): e2405-. Meca-Lallana JE; Oreja-Guevara C; Muñoz D; Olascoaga J; Pato A, Ramió-Torrentà L; Meca-Lallana V; Hernández MA; Marzo ME; Álvarez-Cermeño JC; Rodríguez-Antigüedad A; Montalbán X; Fernández O; Spanish GILENYA Registry Investig "Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.." PLoS One 16 (2021): e0258437-. Walo-Delgado PE; Monreal E; Medina S; Quintana E; Sainz de la Maza S; Fernández-Velasco JI; Lapuente P; Comabella M; Ramió-Torrentà L; Montalban X; Midaglia L; Villarrubia N; Carrasco-Sayalero A; Rodríguez-Martín E; Roldán E; "Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab." Frontiers In Immunology 12 (2021): 760546-. Gonzalez-Del-Rio M; Bertran-Noguer C; Ramió-Torrentà L; Zabaleta-Del-Olmo E; "Disease-related knowledge measurement instruments of people affected by multiple sclerosis: protocol for a systematic psychometric review." BMJ Open 11 (2021): e049580-. Fernandez O; Costa-Frossard L; Martínez-Ginés ML; Montero P; Prieto-González JM; Ramió-Torrentà L; "Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat® Methodology." Frontiers In Neurology 12 (2021): 722801-. Arnoriaga-Rodríguez M, Mayneris-Perxachs J, Coll C, Pérez-Brocal V, Ricart R, Moya A, Ramió-Torrentà L, Pamplona R, Jové M, Portero-Otin M, Fernández-Real JM "Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function." Journal of Internal Medicine 290 (2021): 740-743. Reich DS; Arnold DL, Vermersch P; Bar-Or A; Fox RJ, Matta A; Turner T; Wallström E; Zhang X; Mareš M; Khabirov FA; Traboulsee A; Tolebrutinib Phase 2b Study Group; "Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial." Lancet Neurology 20 (2021): 729-738. Picón C; Tejeda-Velarde A; Fernández-Velasco JI; Comabella M, Álvarez-Lafuente R; Quintana E; Sainz de la Maza S; Monreal E; Villarrubia N; Álvarez-Cermeño JC; Domínguez-Mozo MI; Ramió-Torrentà L; Rodríguez-Martín E; Roldán E "Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis." Frontiers In Immunology 12 (2021): 685139-. Muñoz-San Martín M; Gomez I; Miguela A; Belchí O; Robles-Cedeño R; Quintana E; Ramió-Torrentà L; "Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases." Life-Basel 11 (2021): 594-. Valverde S, Coll L, Valencia L, Clèrigues A, Oliver A, Vilanova JC, Ramió-Torrentà LL, Rovira A, Lladó X "Assessing the Accuracy and Reproducibility of PARIETAL: A Deep Learning Brain Extraction Algorithm." Journal of Magnetic Resonance Imaging (2021): -. Fernández O; Montalban X; Aladro Y; Alonso A; Arroyo R; Calles C; Castillo-Triviño T; Comabella M; Costa-Frossard L; Forero L; Ginestal R; Landete L; Llaneza M; Llufriu S; Martínez-Ginés ML; Meca-Lallana J; Mendibe M; Oreja-G "13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II).." Rev Neurol 72 (2021): 433-442. Fernández O; Montalban X; Aladro Y; Alonso A; Arroyo R; Calles C; Castillo-Triviño T; Comabella M; Costa-Frossard L; Forero L; Ginestal R; Landete L; Llaneza M; Llufriu S; Martínez-Ginés ML; Meca-Lallana J; Mendibe M; Oreja-G "13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I)." Rev Neurol 72 (2021): 397-406. Pérez-Miralles F; Prefasi D; García-Merino A; Ara JR; Izquierdo G; Meca-Lallana V; Gascón-Giménez F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Medrano N; Maurino J; Casanova B; "Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)." Multiple Sclerosis And Related Disorders 50 (2021): 102860-. Escrichs A, Biarnes C, Garre-Olmo J, Fernández-Real JM, Ramos R, Pamplona R, Brugada R, Serena J, Ramió-Torrentà L, Coll-De-Tuero G, Gallart L, Barretina J, Vilanova JC, Mayneris-Perxachs J, Essig M, Figley CR, Pedraza S, Pui "Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club." Cerebral Cortex 31 (2021): 2466-2481. Pérez-Miralles FC; Prefasi D; García-Merino A; Ara JR, Izquierdo G; Meca-Lallana V; Gascón-Giménez F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Maurino J; Carreres-Polo J; Casanova B "Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.." Brain And Behavior 11 (2021): e0244-. Arnoriaga-Rodríguez M, Mayneris-Perxachs J, Contreras-Rodríguez O, Burokas A, Ortega-Sanchez JA, Blasco G, Coll C, Biarnés C, Castells-Nobau A, Puig J, Garre-Olmo J, Ramos R, Pedraza S, Brugada R, Vilanova JC, Serena J, Barre "Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways." Gut 70 (2021): 2283-2296. Cree BAC; Cutter G; Wolinsky JS; Freedman MS; Comi G; Giovannoni G; Hartung HP; Arnold D; Kuhle J; Block V; Munschauer FE; Sedel F; Lublin FD; SPI2 investigative teams; "Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.." Lancet Neurology 19 (2020): 988-997. Toboso I; Tejeda-Velarde A; Alvarez-Lafuente R; Arroyo R; Hegen H; Deisenhammer F; Sainz de la Maza S; Alvarez-Cermeño JC; Izquierdo G; Paramo D; Oliva P; Casanova B; Agüera-Morales E; Franciotta D; Gastaldi M; Fernández O; U "New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab." Frontiers In Neurology 11 (2020): 579438-. Muñoz-San Martín M; Torras S; Robles-Cedeño R; Buxó M; Gómez I; Matute-Blanch C; Comabella M; Villar LM; Perkal H; Quintana E; Ramió-Torrentà L "Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers." Epigenomics 12 (2020): 2065-2076. Arnoriaga-Rodríguez M; Mayneris-Perxachs J; Burokas A; Contreras-Rodríguez O; Blasco G; Coll C; Biarnés C; Miranda-Olivos R; Latorre J; Moreno-Navarrete JM; Castells-Nobau A; Sabater M; Palomo-Buitrago ME; Puig J; Pedraza S; "Obesity impairs short-term and working memory through gut microbial metabolism of aromatic amino acids." Cell Metabolism 32 (2020): 548-560. Hauser SL; Bar-Or A; Cohen JA; Comi G; Correale J; Coyle PK; Cross AH; de Seze J; Leppert D; Montalban X; Selmaj K; Wiendy H; Kerloeguen C; Willi R; Li B; Kakarieka A; Romic D; Goodyear A; Pingili R; Häring DA; Ramanathan K; "Ofatumumab versus Teriflunomide in multiple sclerosis." New England Journal of Medicine 383 (2020): 546-557. Robles-Sanchez MA; Cruz-Díaz V; Amil-Bujan P; Sastre-Garriga J; Ramió-Torrentà L; Bertran-Noguer C "An Expert Patient Program as a Tool to Empower People With Multiple Sclerosis." Journal of Neuroscience Nursing 52 (2020): 166-171. Gil-Varea E; Spataro N; Villar LM; Tejeda-Velarde A; Midaglia L; Matesanz F; Malhotra S; Eixarch H; Patsopoulos N; Fernández Ó; Oliver-Martos B; Saiz A; Llufriu S; Ramió-Torrentà L; Quintana E; Izquierdo G; Alcina A; Bosch E; "Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes." Human Mutation 41 (2020): 1308-1320. Puig J; Biarnes C; Pedraza S; Vilanova JC; Pamplona R; Fernández-Real JM; Brugada R; Ramos R; Coll-de-Tuero G; Calvo-Perxas L; Serena J; Ramió-Torrentà L; Gich J; Gallart L; Portero-Otin M; Alberich-Bayarri A; Jimenez-Pastor "The Aging Imageomics Study: rationale, design and baseline characteristics of the study population." Mechanisms of Ageing and Development 189 (2020): 111257-. Fernández O; Aladro Y; Arroyo R; Brieva L; Calles-Hernández MC; Carrascal P; Comabella M; Costa-Frossard L; Eichau S; García-Merino JA; Ginestal R; González I; Izquierdo G; Martínez-Ginés ML; Meca-Lallana JE; Mendibe-Bilbao M "12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II)." Rev Neurol 70 (2020): 417-429. Fernández O; Aladro Y; Arroyo R; Brieva L; Calles-Hernández MC; Carrascal P; Comabella M; Costa-Frossard L; Eichau S; García-Merino JA; Ginestal R; González I; Izquierdo G; Martínez-Ginés ML; Meca-Lallana JE; Mendibe-Bilbao M "12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)." Rev Neurol 70 (2020): 379-390. Gil-Varea E; Fedetz M; Eixarch H; Spataro N; Villar LM; Urcelay E; Saiz A; Fernández Ó; Leyva L; Ramió-Torrentà L; Vandenbroeck K; Otaegui D; Castillo-Triviño T; Izquierdo G; Malhotra S; Bosch E; Navarro A; Alcina A; Montalba "A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells." Journal of Clinical Medicine 9 (2020): 625-. Tomas-Roig J; Agbemenyah HY; Celarain N; Quintana E; Ramió-Torrentà L; Havemann-Reinecke U. "Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult." Scientific Reports 10 (2020): 590-. Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L "Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions." Journal of Neuroinflammation 16 (2019): art.núm.220-. Oreja-Guevara C; Ayuso Blanco T; Brieva Ruiz ; Hernández Pérez MÁ; Meca-Lallana V; Ramió-Torrentà L. "Cognitive Dysfunctions and Assessments in Multiple Sclerosis.." Frontiers In Neurology 10 (2019): -. Laia Calvó-Perxas; Olga Belchí, Antoni Turón-Estrada; Cecile Van Eendenburg; Marta Linares, Marta Viñas; Anna Manzano; Oriol Turró-Garriga; Joan Vilalta-Franch; Josep Garre-Olmo; on behalf of the Registry of Dementia of Giron "Incidence and characteristics of uncommon dementia subtypes: Results from 10 years of clinical surveillance by the Registry of Dementia of Girona." Alzheimers & Dementia (2019): -. Arnoriaga-Rodríguez M; Blasco G; Coll C; Biarnés C; Contreras-Rodríguez O; Garre-Olmo J; Puig J; Gich J; Ricart W; Ramió-Torrentà L; Fernández-Real JM "Glycated hemoglobin, but not insulin sensitivity, is associated with memory in subjects with obesity." Obesity 27 (2019): 932-942. Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M; Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y; Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; M "Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)." Rev Neurol 68 (2019): 468-479. Pérez-Miralles F; Prefasi D; García-Merino A; Ara JR; Izquierdo G; Meca-Lallana V; Gascón F; Martínez-Ginés ML; Ramió-Torrentà L; Costa-Frossard L; Fernández Ó; Moreno-García S; Maurino J; Casanova-Estruch B "Perception of stigma in patients with primary progressive multiple sclerosis." Multiple sclerosis journal - experimental, translational and clinical 5 (2019): 2055217319-. Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M; Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y; Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; M "Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)." Rev Neurol 68 (2019): 431-441. Valverde, S.;Salem, M;Cabezas, M;Pareto, D;Vilanova, JC;Ramió-Torrentà, L;Rovira, A;Salvi, J.;Oliver, A; Lladó, X. "One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks." NeuroImage: Clinical 21 (2019): 101638-. Robles-Cedeno R; Ramio-Torrenta L "Cladribine in the treatment of relapsing multiple sclerosis." Revista de Neurologia 67 (2018): 343-354. Genís D; Ortega-Cubero S; San Nicolas H; Corral J; Gardenyes J; de Jorge L; Lopez E; Campos B; Lorenzo E; Tonda R; Beltran S; Nere M; Obon M; Beltran B; Fabregas L; Alemany B; Marquez F; Ramió-Torrentà L; Gich J; Volpini V; P "Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48).." Neurology 91 (2018): e1988-e1996. Hervás-García JV; Ramió-Torrentà L; Brieva-Ruiz L; Batllé-Nadal J; Moral E; Blanco Y; Cano-Orgaz A; Presas-Rodríguez S; Torres F; Capellades J; Ramo-Tello C "Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial." European Journal of Neurology (2018): -. Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E "Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.." Journal of Neuroinflammation 15 (2018): 265-. Quintana E; Coll C; Salavedra-Pont J; Muñoz-San Martín M; Robles-Cedeño R; Tomàs-Roig J; Buxó M; Matute-Blanch C; Villar LM; Montalban X; Comabella M; Perkal H; Gich J; Ramió-Torrentà Ll "Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain." European Journal of Neurology 25 (2018): 1189-1191. Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M; Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y; Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; G "Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)." Rev Neurol 67 (2018): 50-62. Casanova B; Lacruz L; Villar ML; Domínguez JA; Gadea MC; Gascón F; Mallada J; Hervás D; Simó-Castelló M; Álvarez-Cermeño JC; Calles C; Olascoaga J; Ramió-Torrentà L; Alcalá C; Cervelló A; Boscá I; Pérez-Miralles FC; Coret F. "Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients." Neurological Sciences 39 (2018): 1423-1430. Ramió-Torrentà L; Álvarez-Cermeño JC; Arroyo R; Casanova-Estruch B; Fernández O; García-Merino JA; Hernández MA; Izquierdo G; Martínez-Yélamos S; Meca J; Moral E; Olascoaga J; Prieto JM; Saiz A "A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis = Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra®) en pacientes con esclerosis múltiple." Neurología 33 (2018): 327-337. Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafue "Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome." Brain: a journal of Neurology 141 (2018): 1085-1093. Tomas-Roig J, Piscitelli F, Gil V, Quintana E, Ramió-Torrentà LL, Del Río JA, Moore TP, Agbemenyah H, Salinas G, Pommerenke C, Lorenzen S, Beißbarth T, Hoyer- Fender S, Di Marzo V, Havemann-Reinecke U "Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: implications for neuropsychiatric disorders." CNS Neuroscience and Therapeutics (2018): -. Sepúlveda M, Aldea M, Escudero D, Llufriu S, Arrambide G, Otero-Romero S, Sastre-Garriga J, Romero-Pinel L, Martínez-Yélamos S, Sola-Valls N, Armangué T, Sotoca J, Escartín A, Robles-Cedeño R, Ramió-Torrentà L, Presas-Rodrígu "Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.." Multiple Sclerosis Journal (2017): -. Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gin "Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).." Revista de Neurologia 65 (2017): 75-84. Moreno-Navarrete JM; Blasco G; Puig J; Biarnés C; Rivero M; Gich J; Fernández-Aranda F; Garre-Olmo J; Ramió-Torrentà L; Alberich-Bayarri Á; García-Castro F; Pedraza S; Ricart W; Fernández-Real JM. "Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance." International Journal of Obesity 41 (2017): 1627-1635. Fernandez O; Oterino A; Oreja-Guevara C; Prieto JM; Mendibe-Bilbao MM; Garcia-Merino JA; Ramio-Torrenta L; Ginestal R; Meca-Lallana JE; Romero-Pinel L; Munoz D; Oliva-Nacarino P; Calles-Hernandez MC; Izquierdo G; Martinez-Gin "Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I)." Revista de Neurologia 65 (2017): 31-40. González-Villà, S.;Valverde, S.;Cabezas, M.;Pareto, D.; Vilanova, J.C.; Ramió-Torrentà, Ll.;Rovira, A.;Oliver, A.; Lladó, X. "Evaluating the effect of multiple sclerosis lesions on automatic brain structure segmentation." NeuroImage: Clinical 15 (2017): 228-238. S. Valverde, M. Cabezas, E. Roura, S. González-Villà, D. Pareto, J.C. Vilanova, Ll. Ramió-Torrentà, À. Rovira, A. Oliver, and X. Lladó "Improving automated multiple sclerosis lesion segmentation with a cascaded 3D convolutional neural network approach." Neuroimage 155 (2017): 159-168. Calvó-Perxas L; Turró-Garriga O; Vilalta-Franch J; Lozano-Gallego M; de Eugenio R; Márquez F; Carmona O; Gich J; Manzano A; Viñas M; Roig AM; Garre-Olmo J; Registry of Dementias of Girona Study Group (ReDeGi Study Group "Trends in the prescription and Long-Term utilization of antidementia drugs among patients with Alzheimer's Disease in Spain: A cohort study using the registry of dementias of Girona.." Drugs & Aging 34 (2017): 303-310. Montalban X; Hauser SL; Kappos L; Arnold DL; Bar-Or A; Comi G; de Seze J; Giovannoni G; Hartung HP; Hemmer B; Lublin F; Rammohan KW; Selmaj K; Traboulsee A; Sauter A; Masterman D; Fontoura P; Belachew S; Garren H; Mairon N; C "Ocrelizumab versus placebo in primary progressive multiple sclerosis." New England Journal of Medicine 376 (2017): 209-220. Hauser SL; Bar-Or A; Comi G; Giovannoni G; Hartung HP; Hemmer B; Lublin F; Montalban X; Rammohan KW; Selmaj K; Traboulsee A; Wolinsky JS; Arnold DL; Klingelschmitt G; Masterman D; Fontoura P; Belachew S; Chin P; Mairon N; Gar "Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.." New England Journal of Medicine 376 (2017): 221-234. Valverde Valverde, Sergi; Oliver i Malagelada, Arnau; Roura Perez, Eloy; González Villà, Sandra; Pareto, Deborah; Vilanova Busquets, Joan Carles; Ramió-Torrentà, Lluís; Rovira, Àlex; Lladó Bardera, Xavier "Automated tissue segmentation of MR brain images in the presence of white matter lesions." Medical Image Analysis 35 (2017): 446-457. Quintana E; Ortega FJ; Robles-Cedeño R; Villar ML; Buxó M; Mercader JM; Alvarez-Cermeño JC; Pueyo N; Perkal H; Fernández-Real JM; Ramió-Torrentà L "miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands." Multiple Sclerosis Journal 1 (2017): -. Rio J; Rovira A; Blanco Y; Sainz A; Perkal H; Robles R; Ramio-Torrenta L; Diaz RM; Arroyo R; Urbaneja P; Fernandez O; Garcia-Merino JA; Reyes MP; Oreja-Guevara C; Prieto JM; Izquierdo G; Olascoaga J; Alvarez-Cermeno JC; Simon "Response to treatment with interferon beta in patients with multiple sclerosis. validation of the Rio Score.." Revista de Neurologia 63 (2016): 145-150. Fernandez O; Rodriguez-Antiguedad A; Olascoaga J; Oreja-Guevara C; Prieto JM; Mendibe-Bilbao MM; Garcia-Merino JA; Ramio-Torrenta L; Ginestal R; Meca-Lallana JE; Romero-Pinel L; Munoz D; Saiz A; Calles-Hernandez MC; Izquierdo "Review of the novelties from the 31st ECTRIMS congress, 2015, presented at the 8th Post-ECTRIMS meeting.." Revista de Neurologia 62 (2016): 559-569. Sepúlveda M; Armangué T; Sola-Valls N; Arrambide G; Meca-Lallana JE; Oreja-Guevara C; Mendibe M; Alvarez de Arcaya A; Aladro Y; Casanova B; Olascoaga J; Jiménez-Huete A; Fernández-Fournier M; Ramió-Torrentà L; Cobo-Calvo A; V "Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus." Neurology: Neuroimmunology and Neuroinflammation 3 (2016): e225-. Ramo-Tello C; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Grau-López L "Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.." Multiple Sclerosis Journal 22 (2016): 117-121. S. Otero-Romero, Ll. Ramió-Torrentà, I. Pericot, O. Carmona, H.Perkal, A. Saiz, E. Bufill, R. Robles, E. Simón, S.Llufriu, J. Vaqué-Rafart, J. Sastre-Garriga, X.Montalban "Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe." Journal of the Neurological Sciences 359 (2015): 146-150. Valverde, S.; Oliver, A.; Roura, E.; Pareto, D.; Vilanova, J.C.;Ramió-Torrentà, Ll.;Sastre-Garriga, J.;Montalban, X.;Rovira, À.;Lladó, X. "Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling." NeuroImage: Clinical 9 (2015): 640-647. Fernandez O; Alvarez-Cermeno JC; Arroyo R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; Garcia-Merino JA; Ginestal R; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao MM; Montalban X; Munoz-Garcia D; Olascoaga "Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).." Revista de Neurologia 61 (2015): 271-283. Villoslada P; Rovira A; Montalban X; Arroyo R; Paul F; Meca-Lallana V; Ramo C; Fernandez O; Saiz A; Garcia-Merino A; Ramió-Torrentà L; Casanova B; Oreja-Guevara C; Muñoz D; Martinez-Rodriguez JE; Lensch E; Prieto JM; Meuth SG "Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.." Neurology: Neuroimmunology and Neuroinflammation 2 (2015): e147-. Fernandez O; Alvarez-Cermeno JC; Arroyo R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; Garcia-Merino JA; Ginestal R; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao MM; Montalban X; Munoz-Garcia D; Olascoaga "Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I).." Revista de Neurologia 61 (2015): 215-224. Gich, J.; Freixenet, J.;Garcia, R.; Vilanova, JC.; Genís, D.; Silva, Y.; Montalban, X.; Ramió-Torrentà, L. "A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project." Multiple Sclerosis Journal 21 (2015): 1344-1348. Oreja-Guevara C; Río J; Gobartt AL; nombre del grupo de investigadores del estudio FUTURA "Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis.." Revista de Neurologia 61 (2015): 145-152. Robles-Cedeño R, Gich J, Genís Batlle D, Ramió-Torrentà L. "Rapidly progressive dementia with false-positive PCR Tropheryma whipplei in CSF. A case of Hashimoto's encephalopathy." Journal of the Neurological Sciences 355 (2015): 213-215. Roura E; Oliver A; Cabezas M; Valverde S; Pareto D; Vilanova JC; Ramió-Torrentà L; Rovira À; Lladó X "A toolbox for multiple sclerosis lesion segmentation. ." Neuroradiology 57 (2015): 1031-1043. Valverde, S.;Oliver, A.;Díez, Y.;Cabezas, M.;Vilanova, JC.;Ramió-Torrentà, LL.;Rovira, À.;Lladó, X. "Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of six Brain Tissue Segmentation Methods." American Journal of Neuroradiology 36 (2015): 1109-1115. Höftberger R; Sepulveda M; Armangue T; Blanco Y; Rostásy K; Calvo AC; Olascoaga J; Ramió-Torrentà L; Reindl M; Benito-León J; Casanova B; Arrambide G; Sabater L; Graus F; Dalmau J; Saiz A. "Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease." Multiple Sclerosis Journal 21 (2015): 866-874. Turró-Garriga O; Calvó-Perxas L; Albaladejo R; Alsina E; Cuy JM; Llinàs-Reglà J; Roig AM; Serena J; Vallmajó N; Viñas M; López-Pousa S; Vilalta-Franch J; Garre-Olmo J; Registry of Dementia of Girona Study Group (ReDeGi Study "Pharmaceutical consumption and cost in patients with dementia: A longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia (Spain)." Archives of Gerontology and Geriatrics 60 (2015): 448-452. Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C "Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.." Multiple Sclerosis Journal 21 (2015): 646-650. Villar LM; Costa-Frossard L; Masterman T; Fernandez O; Montalban X; Casanova B; Izquierdo G; Coret F; Tumani H; Saiz A; Arroyo R; Fink K; Leyva L; Espejo C; Simó-Castelló M; García-Sánchez MI; Lauda F; Llufriú S; Álvarez-Lafu "Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.." Annals of Neurology 77 (2015): 447-457. Espiño M; Abraira V; Arroyo R; Bau L; Cámara C; Campos-Ruiz L; Casanova B; Espejo C; Fernández O; García-Merino A; García-Sánchez MI; Gómez M; Gosis A; Izquierdo G; Meca J; Montalban X; Morandeira F; Olascoaga J; Prada A; Qui "Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.." Clinica Chimica Acta 438 (2015): 67-69. Sauri T; Izquierdo À; Ramió-Torrentà L; Sanchez-Montañez À; Bosch-Barrera J; Porta R "Paraneoplastic Limbic Encephalitis in a Male with Squamous CellCarcinoma of the Lung." Journal Of Clinical Neurology 11 (2015): 87-91. Gich J; Freixanet J; García R; Vilanova JC; Genís D; Silva Y "A randomized; controlled; single-blind; 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.." Multiple Sclerosis Journal 21 (2015): 1332-1343. Grau-Rivera O; Gelpi E; Nos C; Gaig C; Ferrer I; Saiz A; Lladó A; Molinuevo JL; Graus F; Sánchez-Valle R; Neurological Tissue Bank Collaborative Group "Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series." Neurodegenerative Diseases 15 (2015): 350-360. Cabezas, M.;Oliver, A.;Valverde, S.;Beltran, B.;Freixenet, J.;Vilanova, J.C.;Ramió-Torrentà, Ll.;Rovira, À.;Lladó, X. "BOOST: A supervised approach for multiple sclerosis lesion segmentation." Journal of Neuroscience Methods 237 (2014): 108-117. Fernández Ó; Álvarez-Cermeño JC; Arnal-García C; Arroyo-González R; Brieva L; Calles-Hernández MC; Casanova-Estruch B; Comabella M; García-Merino JA; Izquierdo G; Meca-Lallana J; Mendibe-Bilbao Mdel M; Muñoz-García D; Olascoa "Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)." Revista de Neurologia 59 (2014): 371-379. Fernández Ó; Álvarez-Cermeño JC; Arnal-García C; Arroyo-González R; Brieva L; Calles-Hernández MC; Casanova-Estruch B; Comabella M; García-Merino JA; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao Mdel M; Muñoz-García D; Olasco "Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).." Revista de Neurologia 59 (2014): 108-117. Fernandez O; Alvarez-Cermeno JC; Arnal-Garcia C; Arroyo-Gonzalez R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; Garcia-Merino JA; Izquierdo G; Meca-Lallana JE; Mendibe-Bilbao MM; Munoz-Garcia D; Olascoaga "Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)." Revista de Neurologia (2014): -. Calvó-Perxas L; Turró-Garriga O; Aguirregomozcorta M; Bisbe J; Hernández E; López-Pousa S; Manzano A; Palacios M; Pericot-Nierga I; Perkal H; Ramió L; Vilalta-Franch J; Garre-Olmo J; Registry of Dementias of Girona Study Grou "Psychotropic drugs in patients with Alzheimer's Disease: a longitudinal study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain." Journal Of The American Medical Directors Association 15 (2014): 497-503. Cabezas, M; Oliver, A.; Roura, E.; Freixenet, J.; Vilanova, J.C.; Ramió-Torrentà, Ll.; Rovira, A.; Lladó, X. "Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding." Computer Methods and Programs in Biomedicine 155 (2014): 147-161. Diez, Y.;Oliver, A.;Cabezas, M.;Valverde, S.;Martí, R.;Vilanova, J.C.;Ramió-Torrentà, LL.;Rovira, A.;Lladó, X. "Intensity Based Methods for Brain MRI Longitudinal Registration. A Study on Multiple Sclerosis Patients." Neuroinformatics 12 (2014): 365-379. Ganiler, O.; Oliver, A.; Diez, Y.; Freixenet, J.; Vilanova, J.C.; Beltran, B.; Ramió-Torrentà, Ll.; Rovira, A.; Lladó, X. "A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies." Neuroradiology 56 (2014): 363-374. Robles-Cedeño R; Fures JF; Molins A; Muñoz LM; Ramió-Torrentà L "A Moroccan patient with Vogt-Koyanagi-Harada syndrome and bilateral Adie's pupils." Neurological Sciences 35 (2014): 483-485. Confavreux C; O'Connor P; Comi G; Freedman MS; Miller AE; Olsson TP; Wolinsky JS; Bagulho T; Delhay JL; Dukovic D; Truffinet P; Kappos L; TOWER Trial Group "Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial." Lancet Neurology 13 (2014): 247-256. Eloy Roura; Arnau Oliver; Mariano Cabezas; Joan C. Vilanova; Àlex Rovira; Lluís Ramió-Torrentà; Xavier Lladó "MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI." Computer Methods and Programs in Biomedicine 113 (2014): 655-673. Mircea Balasa; Ellen Gelpi; MJ Rey; Jordi Vila; Lluís Ramió-Torrentà; Ana Mª Quiles Granado; Ricard Molina Latorre; Hubert Lepidi; Didier Raoult; Albert Saiz "CLINICAL AND NEUROPATHOLOGICAL VARIABILITY IN CLINICALLY ISOLATED CENTRAL NERVOUS SYSTEM WHIPPLE'S DISEASE.." Brain Pathology (2013): -. Fernandez O; Arnal-Garcia C; Arroyo-Gonzalez R; Brieva L; Calles-Hernandez MC; Casanova-Estruch B; Comabella M; de Las Heras V; Garcia-Merino JA; Hernandez-Perez MA; Izquierdo G; Matas E; Meca-Lallana JE; Mendibe-Bilbao MM; M "Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)." Revista de Neurologia 57 (2013): 269-281. Calvó-Perxas L; López-Pousa S; Turró-Garriga O; de Eugenio R; Linares M; Fernández Mdel M; Castellanos M; Casas I; Turón-Estrada A; Casadevall T; Coromina J; Vilalta-Franch J; Garre-Olmo J; Behalf Of The Registry Of Dementias "Pain treatment and its cost in old people with dementia: a descriptive analysis from the Registry of Dementias of Girona (ReDeGi)." International Journal of Neuroscience 123 (2013): 339-346. Àvila-Castells, P; Garre-Olmo, J; Calvó-Perxas, L; Turró-Garriga, O; Alsina, E; Carmona, O; Perkal, H; Roig, A; Cuy, JM; Lozano, M; Molins, A; Vallmajó, N; López-Pousa, S "Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain)." European Journal of Clinical Pharmacology 69 (2013): 1047-1056. Fernandez, O.; Arnal-Garcia, C.; Arroyo-Gonzalez, R.; Brieva, L.; Calles-Hernandez, M.C.; Casanova-Estruch, B.; Comabella, M.; de Las Heras, V.; Garcia-Merino, J.A.; Hernandez-Perez, M.A.; Izquierdo, G.; Matas, E.; Meca-Lalla "Review of the Novelties Presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (Ectrims) (III)." Revista de Neurologia 57 (2013): 317-329. Sepúlveda M; Blanco Y; Rovira A; Rio J; Mendibe M; Llufriu S; Gabilondo I; Villoslada P; Castilló J; Corral J; Ayuso T; Iñiguez C; Santos S, Guijarro C; Ramió-Torrentà L, Sempere AP; Olascoaga J; Graus F; Montalban X; Saiz A "ANALYSIS OF PROGNOSTIC FACTORS ASSOCIATED WITH LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS.." Multiple Sclerosis Journal 19 (2013): 742-748. Fernández, Ó.; Arroyo-González, R.; Rodríguez-Antigüedad, A.; García-Merino, J.A.; Comabella, M.; Villar, L.M.; Izquierdo, G.; Tintoré, M.; Oreja-Guevara, C.; Álvarez-Cermeño, J.C.; Meca-Lallana, J.E.; Prieto, J.M.; Ramió-Tor "Biomarkers in Multiple Sclerosis." Revista de Neurologia 56 (2013): 375-390. Filippi M; Rocca MA; Pagani E; De Stefano N; Jeffery D; Kappos L; Montalban X; Boyko AN; Comi G; ALLEGRO Study Group "Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage." Journal of Neurology Neurosurgery and Psychiatry 85 (2013): 851-858. Filippi M; Rocca MA; Pagani E; De Stefano N; Jeffery D; Kappos L; Montalban X; Boyko AN; Comi G; ALLEGRO Study Group "Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage." Journal of Neurology Neurosurgery and Psychiatry 85 (2013): 851-858. Fernández, Ó.; Arnal-García, C.; Arroyo-González, R.; Brieva, L.; Calles-Hernández, M.C.; Casanova-Estruch, B.; Comabella, M.; de Las Heras, V.; García-Merino, J.A.; Hernández-Pérez, M.A.; Izquierdo, G.; Matas, E.; Meca-Lalla "Review of the Novelties Presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (Ectrims) (I)." Revista de Neurologia 57 (2013): 217-229. Arnal-Garcia C; García-Montero MR; Málaga I; Millán-Pascual J, Oliva-Nacarino P; Ramió-Torrentà L; Oreja-Guevara C "NATALIZUMAB USE IN PEDIATRIC PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS.." European Journal Of Paediatric Neurology 17 (2013): 50-54. Lladó, X.; Ganiler, O.; Oliver, A.; Martí, R.; Freixenet, J.; Valls, L.; Vilanova, J.C.; Ramió-Torrentà, Ll.; Rovira, A. "Automated detection of muliple sclarosis lesions in serial brain MRI." Neuroradiology 54 (2012): 787-807. López-Pousa S; Calvó-Perxas L; Lejarreta S; Cullell M; Meléndez R; Hernández E; Bisbe J; Perkal H; Manzano A; Roig AM; Turró-Garriga O; Vilalta-Franch J; Garre-Olmo J; Registry of Dementias of Girona Study Group (ReDeGi Study "Use of antidementia drugs in frontotemporal lobar degeneration." American Journal Of Alzheimers Disease And Other Dementias 27 (2012): 260-266. Calvo-Perxas L; Osuna MT; Gich J; Eligio-Hernandez E; Linares M; Vinas M; Casas I; Turro-Garriga O; Lopez-Pousa S; Garre-Olmo J; En Representación Del Grupo de Estudio Del Registro de Demencias de Girona "Clinical and demographic characteristics of the cases of dementia diagnosed in the Health District of Girona throughout the period 2007-2010: data from the Girona Dementia Registry (ReDeGI)." Revista de Neurologia 54 (2012): 399-406. R Robles-Cedeño; L Ramió-Torrentà; G Laguillo; J Gich; M Castellanos "Long-term clinical and radiological evolution in one case of Susac’s syndrome." Neurological Sciences 33 (2012): 1407-1410. Fernandez, O.; Alvarez-Cermeno, J.C.; Arroyo-Gonzalez, R.; Brieva, L.; Calles-Hernandez, M.C.; Casanova-Estruch, B.; Comabella, M.; de las Heras, V.; Garcia-Merino, J.A.; Hernandez-Perez, M.A.; Izquierdo, G.; Meca-Lallana, J. "Review of the Novelties Presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (Ectrims) (II)." Revista de Neurologia 54 (2012): 734-749. Fernández O; Agüera J; Izquierdo G; Millán-Pascual J; *Ramió I Torrentà L; Oliva P; Argente J; Berdei Y; Soler JM; Carmona O; Errea JM; Farrés J; on behalf of the Group on Adherence to IFNb-1b in Spain "ADHERENCE TO INTERFERON beta-1B TREATMENT IN PATIENTS WITH MULTIPLE SCLEROSIS IN SPAIN.." PLoS One 7 (2012): e35600-. Calvó, L.; Eugenio, R.M; Marquez-Daniel, F.; Martínez, R.; Serena, J.; Turbau, J.; Vilalta-Franch, J.; Viñas, M.; Turró-Garriga, O.; Roig, A.M.; López-Pousa, S.; Garre-Olmo, J.; On behalf of the Registry of Dementia of Girona "Profile and variables related to antipsychotic consumption according to dementia subtypes." International Psychogeriatrics 24 (2012): 940-947. Fernández, Ó.; Álvarez-Cermeño, J.C.; Arroyo-González, R.; Brieva, L.; Calles-Hernández, M.C.; Casanova-Estruch, B.; Comabella, M.; de las Heras, V.; García-Merino, J.A.; Hernández-Pérez, M.A.; Izquierdo, G.; Meca-Lallana, J. "Review of the Novelties Presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (Ectrims) (I)." Revista de Neurologia 54 (2012): 677-691. Calvó-Perxas L, López-Pousa S, Vilalta-Franch J, Turró-Garriga O, Blankenburg M; Febrer L; Flaqué M; Vallmajó N; Aguirregomozcorta M; Genís D; Casas I; Perkal H; Coromina J; Garre-Olmo J; Registry of Dementias of Girona Study "Central nervous system drug consumption depending on the time between symptom onset and the diagnosis of Alzheimer's disease: an analysis by the Registry of Dementias of Girona." Dementia and Geriatric Cognitive Disorders 33 (2012): 104-110. Fernández V; Valls-Sole J; Relova JL; Raguer N; Miralles F; Dinca L; Taramundi S; Costa-Frossard L; Ferrandiz M; Ramió-Torrentà L; Villoslada P, Saiz A; Calles C; Antigüedad A; Alvarez-Cermeño JC; Prieto JM, Izquierdo G; Mont "RECOMMENDATIONS FOR THE CLINICAL USE OF MOTOR EVOKED POTENTIALS IN MULTIPLE SCLEROSIS.." Neurología 28 (2012): 408-416. Esteve E; Ricart W; Fernández-Real JM "Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? ." Current Opinion In Clinical Nutrition And Metabolic Care 14 (2011): 483-490. Fernández O; Fernández V; Baumstarck-Barrau K; Muñoz L; Gonzalez Alvarez M del M; Arrabal JC; León A; Alonso A; López-Madrona JC; Bustamante R; Luque G; Guerrero M; di Cantogno EV; Auquier P;*MusiQoL study group of Spain "VALIDATION OF THE SPANISH VERSION OF THE MULTIPLE SCLEROSIS INTERNATIONAL QUALITY OF LIFE (MUSIQOL) QUESTIONNAIRE.." BMC Neurology 11 (2011): 127-. Sastre-Garriga, J.; Rovira, A.; Bonaventura, I.; Escudero-Torrella, J.; Marco-Igual, M.; Aymerich, X.; de Andres, C.; Lacruz, F.; Escartin, A.; Olascoaga, J.; Solar, D.; Farres, J.; Arroyo-Gonzalez, R.; Montalban, X.; Grupo d "Spanish Multi-Centre Observational Study of the First Attacks Suggestive of Multiple Sclerosis: the PREM Cohort." Revista de Neurologia 53 (2011): 577-583. Pozzilli C; Schweikert B; Ecari U; Oentrich W; *BetaPlus Study group "SUPPORTIVE STRATEGIES TO IMPROVE ADHERENCE TO IFN BETA-1B IN MULTIPLE SCLEROSIS--RESULTS OF THE BETAPLUS OBSERVATIONAL COHORT STUDY.." Journal of the Neurological Sciences 307 (2011): 120-126. Blanco, Y.; Ercilla-González, G.; Llufriu, S.; Casanova-Estruch, B.; Magraner, M.J.; Ramió-Torrentá, L.; Mendibe-Bilbao, M.M.; Uclés-Sánchez, A.J.; Casado-Chocán, J.L.; López de Munain, A.; Ramo-Tello, C.; Santos-Lasaosa, S.; "HLA-DRB1 Typing in Caucasians Patiemts With Neuromyelitis Optica." Revista de Neurologia 53 (2011): 146-152. Comi G; Cohen JA; Arnold DL; Wynn D; Filippi M; FORTE Study Group "Phase III dose-comparison study of glatiramer acetate for multiple sclerosis." Annals of Neurology 69 (2011): 75-82. Otero, S.; Batlle, J.; Bonaventura, I.; Brieva, L.; Bufill, E.; Cano, A.; Carmona, O.; Escartin, A.; Marco, M.; Moral, E.; Munteis, E.; Nos, C.; Pericot, I.; Perkal, H.; Ramio-Torrenta, L.; Ramo-Tello, C.; Saiz, A.; Sastre-Ga "Multiple Sclerosis Epidemiological Situation Update: Pertinence and Set-up of a Population Based Registry of New cases in Catalonia." Revista de Neurologia 50 (2010): 623-633. Devonshire V; Lapierre Y; Macdonell R; Ramo-Tello C; Patti F; Fontoura P; SuchetT L; Hyde R; BallaI; Frohman EM; Kieseier BC; FOR THE GAP STUDY GROUP* "THE GLOBAL ADHERENCE PROJECT (GAP): A MULTICENTER OBSERVATIONAL STUDY ON ADHERENCE TO DISEASE-MODIFYING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS.." European Journal of Neurology 18 (2010): 69-77. Blanco Y; Haenkiewicz K; Llufriu S; Sabater L; Graus F; Saiz A; * Grupo español de neuromielitis optica. "CLINICAL SPECTRUM ASSOCIATED WITH AQUAPORIN-4 ANTIBODIES (NMO-IGG).." Neurología 25 (2010): 5-12. Garre-Olmo, J.; Genís, D.; del Mar, M.; Marquez, F.; de Eugenio, R.; Casadevall, T.; Turbau, J.; Turon, A.; López-Pousa, S. "Incidence and subtypes of early-onset dementia in a geographically defined general population." Neurology 74 (2010): 1249-1255. Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A "Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months." Neurology 73 (2009): 949-953. Garre-Olmo J; Flaqué M; Gich J; Pulido TO; Turbau J; Vallmajo N; Viñas M; López-Pousa S; Registry of Dementia of Girona Study Group (ReDeGi Group) "A clinical registry of dementia based on the principle of epidemiological surveillance." BMC Neurology 9 (2009): 5-. Garre-Olmo J; Flaqué M; Gich J; Pulido TO; Turbau J; Vallmajo N; Viñas M; López-Pousa S; Registry of Dementia of Girona Study Group (ReDeGi Group) "A clinical registry of dementia based on the principle of epidemiological surveillance." BMC Neurology 9 (2009): 5-. Genis, D.; Ferrer, I.; Valls-Sole, J.; Corral, J.; Volpini, V.; San Nicolas, H.; Gich, J.; Ramio-Torrenta, L.; Ferrandiz, M.; Puig, J.; Marquez, F. "A Kindred With Cerebellar Ataxia and Thermoanalgesia." Journal of Neurology Neurosurgery and Psychiatry 80 (2009): 518-530. Comi, G.; Martinelli, V.; Rodegher, M.; Moiola, L.; Bajenaru, O.; Carra, A.; Elovaara, I.; Fazekas, F.; Hartung, H.P.; Hillert, J.; King, J.; Komoly, S.; Lubetzki, C.; Montalban, X.; Myhr, K.M.; Ravnborg, M.; Rieckmann, P.; W "Effect of Glatiramer Acetate on Conservation to Clinically Definite Multiple Sclerosis in Patients With Clinically Isolated Syndrome (Precise Study): a Randomised, Double-Blind, Placebo-Controlled Trial." The Lancet 374 (2009): 1503-1511. Aguirregomozcorta M; Ramio-Torrenta L; Gich J; Quiles A; Genis D "PAROXYSMAL DYSTONIA AND PATHOLOGICAL LAUGHTER AS A FIRST MANIFESTATION OFMULTIPLE SCLEROSIS.." Multiple Sclerosis Journal 14 (2008): 262-265. Saiz A; Blanco Y; Sabater L; Gonzalez F; Bataller L; Casamitjana R; Ramio-Torrenta L; Graus F "SPECTRUM OF NEUROLOGICAL SYNDROMES ASSOCIATED WITH GLUTAMIC ACID DECARBOXYLASE ANTIBODIES: DIAGNOSTIC CLUES FOR THIS ASSOCIATION.." Brain: a journal of Neurology 131 (2008): 2553-2563. Ramió-Torrentà L, Sastre-Garriga J, Ingle GT, Davies GR, Ameen V, Miller DH, Thompson AJ. "Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetization transfer study." Journal of Neurology Neurosurgery and Psychiatry 77 (2006): 40-45. Aguirregomozcorta M; Ustrell X; Ramió-Torrentà LL;Serena J "Diagnosis of isolated pulmonary arterio-venous fístula using contrast transcranial Doppler." Neurología 21 (2006): 40-43. Sastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ "Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.." Archives of Neurology 62 (2005): 569-573. Sastre-Garriga J; Ingle GT; Chard DT; Cercignani M; Ramió-Torrentà L, Miller DH; Thompson AJ. "Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study." Brain: a journal of Neurology 128 (2005): 1454-1460. Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; Miller DH; Thompson AJ "Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis." Neuroimage 22 (2004): 353-359. Davies GR; Ramió-Torrentà L, Hadjiprocopis A; Chard DT; Griffin CM; Rashid W; Barker GJ; Kapoor R; Thompson AJ; Miller DH "Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.." Journal of Neurology Neurosurgery and Psychiatry 75 (2004): 998-1002.
Álvarez Bravo, G ; Ramió i Torrentà, L "Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2." Neurología (2020): -.
Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M, Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y, Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; G "Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post- ECTRIMS Meeting (II)." Revista de Neurologia 67 (2018): 50-62. Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M, Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y, Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; G "Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)." Revista de Neurologia 67 (2018): 15-27.